Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine
- PMID: 36330474
- PMCID: PMC9623052
- DOI: 10.3389/fonc.2022.1029491
Coffee reduces the risk of hepatocellular carcinoma probably through inhibition of NLRP3 inflammasome activation by caffeine
Keywords: NLRP3 inflammasome; caffeine; coffee; hepatocellular carcinoma; pyroptosis.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- International Agency for Research on Cancer . Estimated number of new cases from 2020 to 2040, incidence, both sexes, age [0-85+], liver and intrahepatic bile ducts, in: Cancer tomorrow (2022). Available at: https://gco.iarc.fr/tomorrow/en/dataviz/tables?cancers=11 (Accessed September 9, 2022).
-
- Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis. BMJ Open (2017) 7(5):e013739. doi: 10.1136/bmjopen-2016-013739 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
